Target intelligence / Profile preview

Bladder neck tissue

Molecular classification
Other (tissue composed of smooth muscle, urothelium, and connective tissue)
01

Overview

The **bladder neck tissue** is a specialized anatomical structure at the base of the urinary bladder, connecting the bladder to the urethra. It is composed primarily of smooth muscle fibers (internal urethral sphincter) and connective tissue, and plays a critical role in urinary continence by retaining urine in the bladder until voluntary urination occurs. It relaxes during urination to allow urine to pass from the bladder into the urethra. The region contains smooth muscle cells that express alpha-adrenergic receptors, which are a pharmacological target in some lower urinary tract symptoms (LUTS) therapies, but as a bulk tissue, "bladder neck tissue" is not considered a molecule or canonical therapeutic target[1][3][5][7]. Summary: "Urethral/bladder neck tissue" is an anatomical and histological region, not a molecular or canonical drug target. Its role in disease comes from anatomical dysfunction (e.g., obstruction, scarring, inappropriate relaxation) rather than from discrete molecular targeting. Drugs act on molecular targets (e.g., alpha-1 adrenergic receptors) within this tissue, but the tissue itself is not a standard target entity in pharmacology.

Other names
Bladder neckInternal urethral sphincterVesical neck
02

Mechanism of action

Alpha-1 adrenergic receptor blockade (reduces bladder neck smooth muscle tone) Non-specific muscle relaxation (indirect effect of anticholinergic agents)

03

Biological functions

Urinary continence (control of urine flow)Regulation of urine release during micturitionMaintenance of bladder pressure and continence
04

Disease associations

Bladder neck obstruction (benign prostatic hyperplasia, scarring)Urinary incontinenceVoiding dysfunctionNeurogenic bladder
05

Safety considerations

Urinary retention when relaxing the bladder neckPotential for incontinence or impaired emptyingNon-specific drug actions leading to side effects (e.g., postural hypotension with alpha blockers)
06

Interacting drugs

Alpha-adrenergic antagonists (e.g., tamsulosin)

1 more in the full profile.

Beyond the preview

Go deeper on Bladder neck tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bladder neck tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call